Research Chemical Designation & Liability

Compounds indexed in the MinMaxMuscle archive are strictly for laboratory research and development. They are NOT approved for human consumption. Theoretical dosing data is aggregated from clinical literature and must not be construed as medical instruction. Professional medical consultation is mandatory prior to any research application.

Full Disclaimer
Archive Identifier

VIP

Anti-inflammatory

Molecular Dossier

About VIP

Vasoactive Intestinal Peptide — a 28 amino acid neuropeptide with potent anti-inflammatory and immunomodulatory properties. Researched for inflammatory bowel disease, pulmonary inflammation, and neuroprotection via VPAC1/VPAC2 receptors.

Clinical Focus

Systemic Anti-Inflammation & Immune Modulation

Archival Aliases

Vasoactive Intestinal Peptide, VIP-28

Frequently Asked Questions

Clinical Data Matrix

Parameter Clinical Value
Molecular Weight 28 Amino Acid Neuropeptide
Primary Pathway Anti-inflammatory
Research Phase Research Only

Clinical Pros

  • Highly selective receptor modulation
  • Documented efficacy in Phase II trials
  • Minimal systemic cross-reactivity

Research Limitations

  • Limited long-term human data
  • Strict storage and reconstitution requirements
  • Potential for acute homeostatic feedback loops

Community Discussion

Share your questions and experiences with other researchers in the forum.

Discuss in Forum

Clinical Reference Nodes

[REF 1] pubmed.ncbi.nlm.nih.gov
[REF 2] pmc.ncbi.nlm.nih.gov

Data Verified: 2026-04-10

Synergistic Matrix